CSI Market
Sign In | Register

Allergan plc (AGN) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access AGN Annual Income Statement →
This page allows investors to track Allergan plc's income statement performance across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2020)
Q1 2020 		(Dec 31 2019) (Sep 30 2019) (Jun 30 2019) (Mar 31 2019)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax3,604.40
Total Revenue3,604.40
Costs & Expenses
Cost of Goods and Services Sold623.10
Gross Profit2,981.30
Selling, Administration, Marketing1,373.40
Depreciation & Amortization1,416.40
Research and Development Expense430.00
Restructuring, Accretion & Impairment Charges1,061.10
Other operatinig exp. /-income0.00
Total operating costs including COS4,904.00
Operating income / -loss-1,299.60
Interest Expense184.50
Net Interest (-)Expense / Income-184.50
Extinguishment of Debt0.00
Investment Income, Interest21.20
Other loss/ -income3.70
Total costs & expenses5,092.20
Income & Taxes
Income / -loss before income taxes-1,487.80
Income taxes expenses / -benefit-1,866.80
Income after income taxes379.00
Net income / -loss of other equity0.00
Income / -loss from continuing operations379.00
Non-controlling interests-1.00
Net income / -loss379.00
Income / -loss to shareholder378.00
EBIT-1,303.30
EBITD-1,246.50
EBITDA-1,242.40
Earnings Per Share
Basic EPS (excl. extra items)1.15
Basic Net EPS1.15
Basic shares outstanding (Mill. of Units)329.10
Diluted Net EPS1.14
Diluted average shares (Mill. of Units)331.90
Dividend per share0.00
4 historic quarters locked

Sign in to unlock the full Allergan plc income statement history.

Sign In Create Free Account

About AGN Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.